Drug Research
Merck and BioNTech to boost lipid supply for Covid-19 vaccine production
Merck and BioNTech have announced a further expansion of their strategic partnership to accelerate the supply of urgently needed lipids and boost the amount...
News
Effective COVID-19 Vaccine Air Transportation and Handling Requires An Air Cargo Community Approach
TIACA and Pharma.Aero jointly release their second report for the global air cargo and pharmaceutical industries outlining recommended practices and insights for effective COVID-19...
White Papers
AI in tomorrow’s pharma and biotech industry
How to use artificial intelligence to uncover hidden business value in the regulated pharmaceutical and biotech industries
Making AI usable for pharma and biotech industries
As...
News
Europital board forewarns that clinical deficits to slow biotech development in 2021
The newly formed Scientific Advisory Board (SAB) of Europital – a globally-focused, full-service CRO serving small and mid-tier innovators – forewarns that a clinical...
News
Pharmaceutical outsourcing partner predicts AI and dialogue cues will assist HCP engagement
How can pharmaceutical companies leverage digital to engage HCPs in a complex healthcare environment?
Digital transformation has been the leading topic of discussion in most...
Press Releases
AstraZeneca’s Forxiga approved in China for heart failure
AstraZeneca’s Forxiga has been approved in China to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults with...
News
U.S. FDA Approves BMS’s Breyanzi, a New CAR T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma
Bristol Myers Squibb announced that the U.S. FDA has approved Breyanzi, a CD19-directed chimeric antigen receptor (CAR) T cell therapy for the treatment of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read